Search clinical trials for: overexpression of ErbB2 receptors
Total 432206 results
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingOral Cavity NeoplasmUnited States
-
Novartis PharmaceuticalsTerminatedNeoplasms, BreastUnited States, France, Ireland
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedNeoplasms, Gastrointestinal TractTaiwan, Korea, Republic of, China, Japan
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingNon Small Cell Lung Cancer | ERBB2 Mutation-Related Tumors | Disitamab Vedotin | ERBB2 Gene Duplication
-
Array Biopharma, now a wholly owned subsidiary...Completed
-
Novartis PharmaceuticalsActive, not recruitingNeoplasms, Gastrointestinal TractChina, Canada, Estonia, Italy, Turkey, Argentina, Israel, Netherlands, Poland, Russian Federation, Thailand, Brazil, Chile, Hong Kong, Hungary, India, Mexico, Peru, Taiwan, Ukraine, United States, Korea, Republic of, Puerto Rico
-
Novartis PharmaceuticalsTerminatedNeoplasms, BreastSpain, United States, Argentina, Austria, Italy, Russian Federation, Thailand, Brazil, Peru, Philippines, Hong Kong, Mexico
-
GlaxoSmithKlineTerminatedLung Cancer, Non-Small CellUnited States, Canada
-
GlaxoSmithKlineWithdrawnAdvanced Solid TumorsUnited States
-
GlaxoSmithKlineWithdrawn
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Canada, Germany, Spain, Taiwan, Belgium, Philippines, Israel, Hong Kong, Thailand, Pakistan, Russian Federation, Italy, Romania, China, France, Peru, United Kingdom, Czech Republic, Australia, Chile, Korea, Republic of and more
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | KRAS Gene Mutation | Metastatic Malignant Solid Neoplasm | EGFR Gene Mutation | ERBB2 Gene Amplification | ERBB2 Gene Mutation | EGFR Gene Amplification | ERBB3 Gene Mutation | ERBB4 Gene MutationUnited States
-
Array Biopharma, now a wholly owned subsidiary...Completed
-
Novartis PharmaceuticalsTerminatedNeoplasms, BreastBelgium, United States
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedMetastases, BrainSpain, Hungary, Poland, Germany, Italy, Russian Federation, Sweden, United Kingdom, Thailand, United States, Belgium, France, Greece, Denmark
-
GlaxoSmithKlineCompletedNeoplasms, BreastJapan
-
GlaxoSmithKlineCompleted
-
Puma Biotechnology, Inc.CompletedBreast Cancer | Advanced Breast CancerKorea, Republic of, Taiwan, Hong Kong, United States, Japan, Croatia, United Kingdom, Hungary, Australia, Canada, Serbia, Singapore, South Africa, Poland, Spain, Russian Federation, Romania, Austria, Belgium, Bulgaria, Czechia, Fr... and more
-
GlaxoSmithKlineCompletedNeoplasms, BreastTaiwan, Peru, United States, Hong Kong, Chile, India, Mexico, Poland, Pakistan, Singapore, Malaysia
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Canada, Germany, Bulgaria, Spain, Poland, Finland, United Kingdom, Austria, Italy, Greece, Czech Republic, Croatia
-
GlaxoSmithKlineTerminatedNeoplasms, BreastUnited States, Spain, Israel, Canada, Germany, Belgium, Austria, Sweden, Greece, France, Italy
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Australia, Canada, Germany, Argentina, Poland, Russian Federation, Belgium, Spain, Latvia, Netherlands, New Zealand, Mexico, Pakistan, Italy, Austria, Chile, Peru, South Africa, Czech Republic, Hungary, Korea, Republic... and more
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineTerminatedNeoplasms, Breast | Relapsed Breast CancerUnited States
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States
-
China Medical University HospitalTerminated
-
GlaxoSmithKlineCompleted
-
BayerNot yet recruitingAdvanced Non-small Cell Lung Cancer | HER2 MutationUnited States, China, Korea, Republic of, Belgium, Hong Kong, Japan, Taiwan, Denmark, Germany, Israel, Poland, Italy, United Kingdom, Bulgaria, Czechia, Portugal, Switzerland, Greece, Turkey, Romania, Sweden, France, Singapore, Mexico, ... and more
-
National University Hospital, SingaporeNational Cancer Centre, SingaporeUnknownErbB2-Positive Stage I-III Breast CancerSingapore
-
Seagen Inc.National Cancer Institute (NCI); Academic and Community Cancer Research UnitedCompletedMetastatic Colorectal AdenocarcinomaUnited States, Spain, Belgium, France, Italy
-
GlaxoSmithKlineTerminatedNeoplasms, BreastUnited States
-
Novartis PharmaceuticalsCompletedNeoplasms, BreastSpain, Canada, United States, Australia, Austria, Italy, Japan, Poland, Sweden, France, Germany, Switzerland, Taiwan, United Kingdom, Belgium, Greece, India
-
University of ZurichUnknownBreast Cancer | Metastatic Neoplasm | ERBB2Switzerland
-
Novartis PharmaceuticalsCompletedNeoplasms, BreastRussian Federation, China, Brazil, Hong Kong, Pakistan, Peru, Thailand, Ukraine
-
Sun Yat-sen University307 Hospital of PLA; Fudan University; West China Hospital; Tongji Hospital; Second... and other collaboratorsCompletedStomach Neoplasms | ERBB2 Gene Amplification | Neoplasms MetastasisChina
-
GlaxoSmithKlineCompletedSquamous Cell Carcinoma of Head and NeckSpain, France, Peru, India, Greece
-
Thomas GardnerJuvenile Diabetes Research Foundation; Penn State UniversityCompletedDiabetic RetinopathyUnited States
-
GlaxoSmithKlineCompletedNeoplasms, BreastKorea, Republic of, Canada, United States
-
Duke UniversityGenentech, Inc.; Novartis PharmaceuticalsCompletedMetastatic Breast CancerUnited States
-
Novartis PharmaceuticalsCompletedNeoplasms, BreastUnited States
-
GlaxoSmithKlineCompletedNeoplasms, BreastPoland, Russian Federation, Latvia, Romania
-
University of PennsylvaniaWithdrawnBreast CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Massachusetts General Hospital; Washington University School of Medicine; Gla... and other collaboratorsCompletedNeurofibromatosis 2 | Vestibular Schwannoma | Acoustic Neuroma | NF2 | Auditory TumorUnited States
-
Central European Cooperative Oncology GroupTerminatedMetastatic Breast CancerHungary, Austria
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Australia, Germany, Hungary, Poland, Peru, France, Israel, Russian Federation, Spain, Canada, Denmark, Hong Kong, Latvia, Korea, Republic of, China, Belgium, Philippines, Italy, United Kingdom, Argentina, India, New Zealand and more
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedRecurrent Uterine Corpus Carcinoma | Endometrial Adenocarcinoma | Stage III Uterine Corpus Cancer AJCC v7 | Stage IV Uterine Corpus Cancer AJCC v7 | ERBB2 Gene AmplificationUnited States
-
AstraZenecaDaiichi SankyoActive, not recruitingHER2-mutant Non-Small Cell Lung CancerChina